Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Whittle

Showing results (31-40 of 497) with videos related to

Pageof 50
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1989
The defensive role played by the gastric microcirculationB J Whittle
The Proceedings of the Nutrition Society|February 1, 1985
A vital role for aquatic resources in feeding a hungry worldK J Whittle
British Journal of Pharmacology|November 1, 1978
Inhibition of prostacyclin (PGI2) formation in the rat small-intestine and gastric mucosa by the ulcerogen, indomethacin [proceedings]B J Whittle
Lancet (London, England)|February 11, 1998
Early amniocentesis: time for a rethinkM J Whittle
Polish Journal of Pharmacology and Pharmacy|March 1, 1978
Inhibition of gastric acid secretion and gastric erosions by prostacyclin and other prostaglandinsB J Whittle
The Journal of Physiology|August 1, 1978
Actions of a proposed endogenous inhibitor of prostaglandin synthetase from plasma on cyclo-oxygenase activity in platelets and gastric mucosa [proceedings]B J Whittle
Gastroenterology|January 1, 1981
Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the ratB J Whittle
Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|January 1, 1990
Imaging problems in obstetricsM J Whittle
Italian Journal of Gastroenterology and Hepatology|June 24, 1999
Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathyB J Whittle
Gut|August 15, 2000
COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitorsB J Whittle
Pageof 50

Showing results (31-40 of 497) with videos related to

Sort By:
Pageof 50
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1989
The defensive role played by the gastric microcirculationB J Whittle
The Proceedings of the Nutrition Society|February 1, 1985
A vital role for aquatic resources in feeding a hungry worldK J Whittle
British Journal of Pharmacology|November 1, 1978
Inhibition of prostacyclin (PGI2) formation in the rat small-intestine and gastric mucosa by the ulcerogen, indomethacin [proceedings]B J Whittle
Lancet (London, England)|February 11, 1998
Early amniocentesis: time for a rethinkM J Whittle
Polish Journal of Pharmacology and Pharmacy|March 1, 1978
Inhibition of gastric acid secretion and gastric erosions by prostacyclin and other prostaglandinsB J Whittle
The Journal of Physiology|August 1, 1978
Actions of a proposed endogenous inhibitor of prostaglandin synthetase from plasma on cyclo-oxygenase activity in platelets and gastric mucosa [proceedings]B J Whittle
Gastroenterology|January 1, 1981
Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the ratB J Whittle
Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fur Medizinische Physik and the European Federation of Organisations for Medical Physics|January 1, 1990
Imaging problems in obstetricsM J Whittle
Italian Journal of Gastroenterology and Hepatology|June 24, 1999
Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathyB J Whittle
Gut|August 15, 2000
COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitorsB J Whittle
Pageof 50